Randomized, Double-Blind, Placebo and Active Controlled Study of the Activity of SAR407899A Single-Dose on the Ability to Increase Duration of Penile Rigidity, Under Experimental Condition, in Patients With Mild to Moderate Erectile Dysfunction (ED).

Trial Profile

Randomized, Double-Blind, Placebo and Active Controlled Study of the Activity of SAR407899A Single-Dose on the Ability to Increase Duration of Penile Rigidity, Under Experimental Condition, in Patients With Mild to Moderate Erectile Dysfunction (ED).

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2012

At a glance

  • Drugs SAR 407899; Sildenafil
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms RHOKET
  • Most Recent Events

    • 13 May 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.
    • 07 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top